Report Detail
Global Chemotherapy-induced Nausea and Vomiting Drugs Market Insights and Forecast to 2026
- RnM4136465 |
- 14 August, 2020 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
Chemotherapy-induced Nausea and Vomiting Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chemotherapy-induced Nausea and Vomiting Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Chemotherapy-induced Nausea and Vomiting Drugs market is segmented into
5-HT3 Inhibitors
NK1 Inhibitors
Other
Segment by Application, the Chemotherapy-induced Nausea and Vomiting Drugs market is segmented into
Highly Emetogenic Chemotherapy
Moderately Emetogenic Chemotherapy
Low Emetogenic Chemotherapy
Other
Regional and Country-level Analysis
The Chemotherapy-induced Nausea and Vomiting Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Chemotherapy-induced Nausea and Vomiting Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Chemotherapy-induced Nausea and Vomiting Drugs Market Share Analysis
Chemotherapy-induced Nausea and Vomiting Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Chemotherapy-induced Nausea and Vomiting Drugs business, the date to enter into the Chemotherapy-induced Nausea and Vomiting Drugs market, Chemotherapy-induced Nausea and Vomiting Drugs product introduction, recent developments, etc.
The major vendors covered:
Merck
Eisai
Mundipharma
Qilu Pharma
Teva
Novartis
Heron Therapeutics
Roche
Mylan
Tesaro
1 Study Coverage
- 1.1 Chemotherapy-induced Nausea and Vomiting Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key Chemotherapy-induced Nausea and Vomiting Drugs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size Growth Rate by Type
- 1.4.2 5-HT3 Inhibitors
- 1.4.3 NK1 Inhibitors
- 1.4.4 Other
- 1.5 Market by Application
- 1.5.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size Growth Rate by Application
- 1.5.2 Highly Emetogenic Chemotherapy
- 1.5.3 Moderately Emetogenic Chemotherapy
- 1.5.4 Low Emetogenic Chemotherapy
- 1.5.5 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size, Estimates and Forecasts
- 2.1.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue 2015-2026
- 2.1.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales 2015-2026
- 2.2 Global Chemotherapy-induced Nausea and Vomiting Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Chemotherapy-induced Nausea and Vomiting Drugs Competitor Landscape by Players
- 3.1 Chemotherapy-induced Nausea and Vomiting Drugs Sales by Manufacturers
- 3.1.1 Chemotherapy-induced Nausea and Vomiting Drugs Sales by Manufacturers (2015-2020)
- 3.1.2 Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Manufacturers (2015-2020)
- 3.2 Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Manufacturers
- 3.2.1 Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Manufacturers (2015-2020)
- 3.2.2 Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Chemotherapy-induced Nausea and Vomiting Drugs Revenue in 2019
- 3.2.5 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Chemotherapy-induced Nausea and Vomiting Drugs Price by Manufacturers
- 3.4 Chemotherapy-induced Nausea and Vomiting Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Chemotherapy-induced Nausea and Vomiting Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Chemotherapy-induced Nausea and Vomiting Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Chemotherapy-induced Nausea and Vomiting Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Type (2015-2020)
- 4.1.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2015-2020)
- 4.1.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type (2015-2020)
- 4.1.3 Chemotherapy-induced Nausea and Vomiting Drugs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast by Type (2021-2026)
- 4.2.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Forecast by Type (2021-2026)
- 4.2.3 Chemotherapy-induced Nausea and Vomiting Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Application (2015-2020)
- 5.1.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2015-2020)
- 5.1.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Application (2015-2020)
- 5.1.3 Chemotherapy-induced Nausea and Vomiting Drugs Price by Application (2015-2020)
- 5.2 Chemotherapy-induced Nausea and Vomiting Drugs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast by Application (2021-2026)
- 5.2.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Chemotherapy-induced Nausea and Vomiting Drugs by Country
- 6.1.1 North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country
- 6.1.2 North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Chemotherapy-induced Nausea and Vomiting Drugs Market Facts & Figures by Type
- 6.3 North America Chemotherapy-induced Nausea and Vomiting Drugs Market Facts & Figures by Application
7 Europe
- 7.1 Europe Chemotherapy-induced Nausea and Vomiting Drugs by Country
- 7.1.1 Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country
- 7.1.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Facts & Figures by Type
- 7.3 Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs by Region
- 8.1.1 Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales by Region
- 8.1.2 Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Market Facts & Figures by Type
- 8.3 Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Chemotherapy-induced Nausea and Vomiting Drugs by Country
- 9.1.1 Latin America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country
- 9.1.2 Latin America Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Chemotherapy-induced Nausea and Vomiting Drugs Market Facts & Figures by Type
- 9.3 Central & South America Chemotherapy-induced Nausea and Vomiting Drugs Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs by Country
- 10.1.1 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country
- 10.1.2 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Market Facts & Figures by Type
- 10.3 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Market Facts & Figures by Application
11 Company Profiles
- 11.1 Merck
- 11.1.1 Merck Corporation Information
- 11.1.2 Merck Description and Business Overview
- 11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Merck Chemotherapy-induced Nausea and Vomiting Drugs Products Offered
- 11.1.5 Merck Related Developments
- 11.2 Eisai
- 11.2.1 Eisai Corporation Information
- 11.2.2 Eisai Description and Business Overview
- 11.2.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Eisai Chemotherapy-induced Nausea and Vomiting Drugs Products Offered
- 11.2.5 Eisai Related Developments
- 11.3 Mundipharma
- 11.3.1 Mundipharma Corporation Information
- 11.3.2 Mundipharma Description and Business Overview
- 11.3.3 Mundipharma Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Mundipharma Chemotherapy-induced Nausea and Vomiting Drugs Products Offered
- 11.3.5 Mundipharma Related Developments
- 11.4 Qilu Pharma
- 11.4.1 Qilu Pharma Corporation Information
- 11.4.2 Qilu Pharma Description and Business Overview
- 11.4.3 Qilu Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Qilu Pharma Chemotherapy-induced Nausea and Vomiting Drugs Products Offered
- 11.4.5 Qilu Pharma Related Developments
- 11.5 Teva
- 11.5.1 Teva Corporation Information
- 11.5.2 Teva Description and Business Overview
- 11.5.3 Teva Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Teva Chemotherapy-induced Nausea and Vomiting Drugs Products Offered
- 11.5.5 Teva Related Developments
- 11.6 Novartis
- 11.6.1 Novartis Corporation Information
- 11.6.2 Novartis Description and Business Overview
- 11.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Novartis Chemotherapy-induced Nausea and Vomiting Drugs Products Offered
- 11.6.5 Novartis Related Developments
- 11.7 Heron Therapeutics
- 11.7.1 Heron Therapeutics Corporation Information
- 11.7.2 Heron Therapeutics Description and Business Overview
- 11.7.3 Heron Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Products Offered
- 11.7.5 Heron Therapeutics Related Developments
- 11.8 Roche
- 11.8.1 Roche Corporation Information
- 11.8.2 Roche Description and Business Overview
- 11.8.3 Roche Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Roche Chemotherapy-induced Nausea and Vomiting Drugs Products Offered
- 11.8.5 Roche Related Developments
- 11.9 Mylan
- 11.9.1 Mylan Corporation Information
- 11.9.2 Mylan Description and Business Overview
- 11.9.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Mylan Chemotherapy-induced Nausea and Vomiting Drugs Products Offered
- 11.9.5 Mylan Related Developments
- 11.10 Tesaro
- 11.10.1 Tesaro Corporation Information
- 11.10.2 Tesaro Description and Business Overview
- 11.10.3 Tesaro Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Products Offered
- 11.10.5 Tesaro Related Developments
- 11.1 Merck
- 11.1.1 Merck Corporation Information
- 11.1.2 Merck Description and Business Overview
- 11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Merck Chemotherapy-induced Nausea and Vomiting Drugs Products Offered
- 11.1.5 Merck Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Chemotherapy-induced Nausea and Vomiting Drugs Market Estimates and Projections by Region
- 12.1.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast by Regions 2021-2026
- 12.1.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Forecast by Regions 2021-2026
- 12.2 North America Chemotherapy-induced Nausea and Vomiting Drugs Market Size Forecast (2021-2026)
- 12.2.1 North America: Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast (2021-2026)
- 12.2.2 North America: Chemotherapy-induced Nausea and Vomiting Drugs Revenue Forecast (2021-2026)
- 12.2.3 North America: Chemotherapy-induced Nausea and Vomiting Drugs Market Size Forecast by Country (2021-2026)
- 12.3 Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size Forecast (2021-2026)
- 12.3.1 Europe: Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast (2021-2026)
- 12.3.2 Europe: Chemotherapy-induced Nausea and Vomiting Drugs Revenue Forecast (2021-2026)
- 12.3.3 Europe: Chemotherapy-induced Nausea and Vomiting Drugs Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Chemotherapy-induced Nausea and Vomiting Drugs Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Chemotherapy-induced Nausea and Vomiting Drugs Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Chemotherapy-induced Nausea and Vomiting Drugs Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast (2021-2026)
- 12.5.2 Latin America: Chemotherapy-induced Nausea and Vomiting Drugs Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Chemotherapy-induced Nausea and Vomiting Drugs Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Chemotherapy-induced Nausea and Vomiting Drugs Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Chemotherapy-induced Nausea and Vomiting Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Chemotherapy-induced Nausea and Vomiting Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Chemotherapy-induced Nausea and Vomiting Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Chemotherapy-induced Nausea and Vomiting Drugs. Industry analysis & Market Report on Chemotherapy-induced Nausea and Vomiting Drugs is a syndicated market report, published as Global Chemotherapy-induced Nausea and Vomiting Drugs Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Chemotherapy-induced Nausea and Vomiting Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
